Robert N. Cavanaugh - 02 Jul 2024 Form 4 Insider Report for Accolade, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Jul 2024, 09:34:23 UTC
Prior SEC filing
20 Jun 2024
Next SEC filing
12 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard Eskew, Attorney-in-Fact

Key filing fact

Robert N. Cavanaugh filed Form 4 for Accolade, Inc. on 03 Jul 2024.

Key facts

  • This page summarizes Robert N. Cavanaugh's Form 4 filing for Accolade, Inc..
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Jul 2024, 09:34.

Change

  • Previous filing in this sequence was filed on 20 Jun 2024.
  • Current net transaction value: -$1,618.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACCD transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,568
Change %
+0.83%
Price
Shares after
191,331
Date
02 Jul 2024
Ownership
Direct
Footnotes
F1
ACCD transaction

Common Stock

Sale

Transaction value
$1,618
Shares
-457
Change %
-0.24%
Price
$3.54*
Shares after
190,874
Date
02 Jul 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACCD transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,568
Change %
-4.2%
Price
Shares after
36,075
Date
02 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,568
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") converted into one share of the Issuer's common stock.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "mandatory sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

Each RSU represents the contingent right to receive one share of the Issuer's common stock.

Footnote F4

The Reporting Person was granted restricted stock units ("RSUs") on June 27, 2023 with a vesting commencement date of June 1, 2023 (the "Vesting Commencement Date"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs will vest as follows: (a) one-third (1/3rd) of the RSUs will vest on the first anniversary of the Vesting Commencement Date (or June 1, 2024), and (b) then 1/36th of the RSUs will vest on each successive month following the first anniversary of the Vesting Commencement Date, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .